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Background
Colloidal silica is an inorganic substance widely used as
excipient in pharmaceutical preparation. It acts as a vehi-
cule to increase the absorption of many oral drug formula-
tions. Many excipients have been reported to induce drug
hypersensitivity such as tartrazine, aspartame, benzalko-
nium chloride, sodium metabisulphite, propyl gallate.
However, colloidal silica has never been reported to
induce hypersensitivity. We report herein a case of colloi-
dal silica-induced hypersensitivity confirmed by a positive
patch test.
Case report
A 40-year-old patient was prescribed diclofenac (Voltar-
ene® 50 mg enteric coated tablet, Novartis) for a right
goneitis. On the second day of treatment, he presented a
generalized maculo-papular eruption with neither fever
nor lymph node swelling. Laboratory findings showed
eosinophilia (500 cells/µL) with normal hepatic and renal
function. Voltarene® was discontinued and the symptoms
had resolved one week later. One month after total
recovery, a patch test to diclofenac (Voltarene®, 50 mg
enteric coated tablet, Novartis) was performed on the
back of the patient, and was positive. In order to investi-
gate cross reactivity, we performed a patch test to other
non steroidal anti-inflammatory drugs (NSAID), i.e; pir-
oxicam (Piroxen®), ketoprofen (Oki®), indometacine
(Indocid®), tiaprofenic acid (Surgam®), acetyl salicylic
acid (Aspegic®). These tests were positives only for pirox-
icam, ketoprofen and indometacine. When examining
different NSAID formulations used in patch testing, we
found that colloidal silica was present in tablets of volta-
nene®, Piroxen®, Oki®, Indocid® and was absent in
Surgam® and Aspegic®. So that, a patch test to colloidal
silica was performed (10% in petrolatum) and was posi-
tive at 48h reading. A control patch test was conducted
in three healthy controls following to the same procedure
and was negative in all of them.
Conclusion
To the best of our knowledge, this case is the first to
describe a skin hypersensitivity induced by colloidal
silica confirmed by a positive patch test.
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